Patents by Inventor Tammy Wang

Tammy Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060293281
    Abstract: The present invention provides novel ureas containing N-aryl or N-heteroaryl substituted heterocycles of Formula (I): or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, B, D and W are as defined herein. These compounds are selective inhibitors of the human P2Y1 receptor which can be used as medicaments.
    Type: Application
    Filed: June 26, 2006
    Publication date: December 28, 2006
    Applicant: Bristol-Myers Squibb Company
    Inventors: Jennifer Qiao, Tammy Wang, James Sutton, Timur Gungor
  • Patent number: 6992102
    Abstract: The invention provides compounds of the formula I wherein the substitutents are as described herein. Further provided are methods of using such compounds for the treatment of nuclear hormone receptor-associated conditions, such as age related diseases, for example sarcopenia, and also provided are pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: October 14, 2003
    Date of Patent: January 31, 2006
    Assignee: Bristol-Myers Squibb Company
    Inventors: Lawrence Hamann, David Augeri, Chongqing Sun, Jeffrey A. Robl, Mark E. Salvati, Tammy Wang
  • Publication number: 20050267119
    Abstract: The present invention provides novel pyridyl or phenyl ureas and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
    Type: Application
    Filed: May 11, 2005
    Publication date: December 1, 2005
    Inventors: Hannguang Chao, Huji Tuerdi, Timothy Herpin, Jacques Roberge, Yalei Liu, R. Lawrence, Robert Rehfuss, Charles Clark, Jennifer Qiao, Timur Gungor, Patrick Lam, Tammy Wang, Rejean Ruel, Alexandre L'Heureux, Carl Thibeault, Gilles Bouthillier, Dora Schnur
  • Publication number: 20050261244
    Abstract: The present invention provides novel ureas containing N-aryl or N-heteroaryl substituted heterocycles and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
    Type: Application
    Filed: May 10, 2005
    Publication date: November 24, 2005
    Inventors: Huji Tuerdi, Hannguang Chao, Jennifer Qiao, Tammy Wang, Timur Gungor
  • Publication number: 20050197359
    Abstract: The present invention relates to bicyclic compounds according to formula I, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of androgen receptor-associated conditions, such as age-related diseases, for example sarcopenia, wherein R1, R2, R5, X, Y and n are defined herein.
    Type: Application
    Filed: March 2, 2005
    Publication date: September 8, 2005
    Inventors: Alexandra Nirschl, James Sutton, Lawrence Hamann, Tammy Wang, Yan Zou, Chongqing Sun
  • Publication number: 20040181064
    Abstract: The invention provides compounds according to formula I 1
    Type: Application
    Filed: February 17, 2004
    Publication date: September 16, 2004
    Inventors: Chong-Qing Sun, Lawrence Hamann, David Augeri, Yingzhi Bi, Jeffrey Robl, Yan-Ting Huang, Tammy Wang, Alexandra Holubec, Ligaya Simpkins, James C. Sutton, James J. Li
  • Publication number: 20040019063
    Abstract: The invention provides for a pharmaceutical composition capable of modulating the androgen receptor comprising a compound of formula I 1
    Type: Application
    Filed: May 15, 2003
    Publication date: January 29, 2004
    Inventors: Chongqing Sun, Lawrence Hamann, David Augeri, Yingzhi Bi, Jeffrey Robl, Yanting Huang, Tammy Wang, Alexandra Holubec, Ligaya Simpkins
  • Patent number: 6670386
    Abstract: The invention provides compounds of the formula I wherein the substitutents are as described herein. Further provided are methods of using such compounds for the treatment of nuclear hormone receptor-associated conditions, such as age related diseases, for example sarcopenia, and also provided are pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: July 31, 2002
    Date of Patent: December 30, 2003
    Assignee: Bristol-Myers Squibb Company
    Inventors: Chongqing Sun, Jeffrey A. Robl, Mark E. Salvati, Tammy Wang, Lawrence Hamann, David Augeri
  • Publication number: 20030055094
    Abstract: The invention provides compounds of the formula I 1
    Type: Application
    Filed: July 31, 2002
    Publication date: March 20, 2003
    Inventors: Chongqing Sun, Jeffrey A. Robl, Mark E. Salvati, Tammy Wang, Lawrence Hamann, David Augeri